Lee Dong-Yun
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Menopausal Med. 2025 Aug;31(2):85-94. doi: 10.6118/jmm.25109.
Diminished ovarian reserve (DOR) occurs unintentionally during treatment or spontaneously. Despite its significant clinical manifestations, such as infertility and early menopause, and its high prevalence, most studies on DOR have focused on premature ovarian insufficiency, and reviews specifically addressing DOR remain scarce. This narrative review aims to provide insight into the diverse etiologies of DOR while discussing promising therapeutic approaches. Iatrogenic DOR can occur during chemotherapy, pelvic radiation, and ovarian surgery. Spontaneous DOR may result from ovarian tumors as well as idiopathic or genetic causes. DOR also inevitably occurs during ovarian fragment transplantation. Stem cell transplantation, in vitro activation, and platelet-rich plasma injection have shown some positive results as therapeutic approaches to DOR; however, more high-quality studies are needed to establish their broader applications in clinical practice.
卵巢储备功能减退(DOR)可在治疗期间意外发生,也可自发出现。尽管其有诸如不孕和早绝经等显著临床表现,且患病率高,但大多数关于DOR的研究都集中在卵巢早衰上,专门针对DOR的综述仍然很少。本叙述性综述旨在深入探讨DOR的多种病因,同时讨论有前景的治疗方法。医源性DOR可发生在化疗、盆腔放疗和卵巢手术期间。自发性DOR可能由卵巢肿瘤以及特发性或遗传原因引起。DOR在卵巢组织移植过程中也不可避免地会发生。干细胞移植、体外激活和富血小板血浆注射作为DOR的治疗方法已显示出一些积极结果;然而,需要更多高质量研究来确定它们在临床实践中的更广泛应用。